Natural diversity of potato (Solanum tuberosum) invertases

Por Draffehn, Astrid M, Meller, Sebastian, Li, Li, Gebhardt, Christiane
Publicado em 2010

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites

Por Jung, Maria, Pützer, Svenja, Gevensleben, Heidrun, Meller, Sebastian, Kristiansen, Glen, Dietrich, Dimo
Publicado no Clin Epigenetics (2016)

The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer

Por Bicker, Anne, Brahmer, Alexandra M., Meller, Sebastian, Kristiansen, Glen, Gorr, Thomas A., Hankeln, Thomas
Publicado no PLoS One (2015)

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition

Por Dietrich, Dimo, Uhl, Barbara, Sailer, Verena, Holmes, Emily Eva, Jung, Maria, Meller, Sebastian, Kristiansen, Glen
Publicado em 2013

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions

Por Dietrich, Dimo, Jung, Maria, Puetzer, Svenja, Leisse, Annette, Holmes, Emily Eva, Meller, Sebastian, Uhl, Barbara, Schatz, Philipp, Ivascu, Claudia, Kristiansen, Glen
Publicado em 2013

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients

Por Meller, Sebastian, Zipfel, Lisa, Gevensleben, Heidrun, Dietrich, Jörn, Ellinger, Jörg, Majores, Michael, Stein, Johannes, Sailer, Verena, Jung, Maria, Kristiansen, Glen, Dietrich, Dimo
Publicado no Epigenetics (2016)

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy

Por Holmes, Emily Eva, Goltz, Diane, Sailer, Verena, Jung, Maria, Meller, Sebastian, Uhl, Barbara, Dietrich, Jörn, Röhler, Magda, Ellinger, Jörg, Kristiansen, Glen, Dietrich, Dimo
Publicado no Clin Epigenetics (2016)

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients

Por Goltz, Diane, Holmes, Emily Eva, Gevensleben, Heidrun, Sailer, Verena, Dietrich, Jörn, Jung, Maria, Röhler, Magda, Meller, Sebastian, Ellinger, Jörg, Kristiansen, Glen, Dietrich, Dimo
Publicado no Oncotarget (2016)

Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine

Por Holmes, Emily Eva, Jung, Maria, Meller, Sebastian, Leisse, Annette, Sailer, Verena, Zech, Julie, Mengdehl, Martina, Garbe, Leif-Alexander, Uhl, Barbara, Kristiansen, Glen, Dietrich, Dimo
Publicado em 2014

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas

Por Semaan, Alexander, van Ellen, Anne, Meller, Sebastian, Bergheim, Dominik, Branchi, Vittorio, Lingohr, Philipp, Goltz, Diane, Kalff, Jörg C., Kristiansen, Glen, Matthaei, Hanno, Pantelis, Dimitrios, Dietrich, Dimo
Publicado no Clin Epigenetics (2016)

Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer

Por Meller, Sebastian, Meyer, Hellmuth-A, Bethan, Bianca, Dietrich, Dimo, Maldonado, Sandra González, Lein, Michael, Montani, Matteo, Reszka, Regina, Schatz, Philipp, Peter, Erik, Stephan, Carsten, Jung, Klaus, Kamlage, Beate, Kristiansen, Glen
Publicado no Oncotarget (2015)